Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Semtech Corporation(SMTC) | 2,452,855 | 2,577,855 | +125,000 | $63.16M | $56.48M | 50.44% | -$6.68M |
| Marinus Pharmaceuticals Inc | 2,145,337 | 2,134,337 | -11,000 | $17.27M | $23.20M | 20.72% | +$5.93M |
| Ardelyx Inc | 1,176,667 | 1,151,667 | -25,000 | $4.80M | $7.14M | 6.38% | +$2.34M |
| Milestone Pharmaceuticals Inc.(MIST) | 450,207 | 1,650,207 | +1,200,000 | $1.40M | $2.76M | 2.46% | +$1.36M |
| Harpoon Therapeutics Inc | 82,458 | 228,900 | +146,442 | $332.3K | $2.60M | 2.32% | +$2.27M |
| Burgerfi International Inc | 2,745,938 | 2,745,938 | 0 | $3.19M | $2.36M | 2.11% | -$824.1K |
| Kiniksa Pharmaceuticals LtdCL A | 130,691 | 130,691 | 0 | $2.27M | $2.29M | 2.05% | +$22.2K |
| Insmed Incorporated(INSM) | 70,335 | 70,335 | 0 | $1.78M | $2.18M | 1.95% | +$403.7K |
| Battalion Oil Corporation(BATL) | 380,891 | 222,182 | -158,709 | $2.35M | $2.14M | 1.91% | -$218.7K |
| Cymabay Therapeutics Inc | 82,425 | 82,425 | 0 | $1.23M | $1.95M | 1.74% | +$717.9K |
| Fennec Pharmaceuticals Inc.(FENC) | 110,000 | 110,000 | 0 | $826.1K | $1.23M | 1.10% | +$408.1K |
| Avadel Pharmaceuticals PlcADR | 80,000 | 80,000 | 0 | $824.0K | $1.13M | 1.01% | +$305.6K |
| Enphys Acquisition CorpCL A | 0 | 78,125 | +78,125 | $0 | $833.6K | 0.74% | +$833.6K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 34,500 | 34,500 | 0 | $500.9K | $745.5K | 0.67% | +$244.6K |
| Bluebird Bio Inc | 531,256 | 531,256 | 0 | $1.62M | $733.1K | 0.65% | -$881.9K |
| Travere Therapeutics, Inc.(TVTX) | 78,000 | 78,000 | 0 | $697.3K | $701.2K | 0.63% | +$3.9K |
| Travere Therapeutics, Inc.NOTE 2 250 3 0(TVTX) | 0 | 0 | 0 | $647.9K | $670.7K | 0.60% | +$22.8K |
| Humacyte, Inc.(HUMA) | 235,000 | 235,000 | 0 | $688.5K | $667.4K | 0.60% | -$21.1K |
| Seres Therapeutics, Inc.(MCRB) | 691,803 | 340,761 | -351,042 | $1.65M | $477.1K | 0.43% | -$1.17M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 27,000 | 13,500 | -13,500 | $853.2K | $398.5K | 0.36% | -$454.7K |
| Replimune Group, Inc.(REPL) | 35,000 | 42,500 | +7,500 | $598.9K | $358.3K | 0.32% | -$240.6K |
| Lumos Pharma Inc | 90,794 | 90,794 | 0 | $299.6K | $288.7K | 0.26% | -$10.9K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 14,000 | +14,000 | $0 | $206.1K | 0.18% | +$206.1K |
| Whitehawk Therapeutics, Inc.(WHWK) | 82,423 | 82,423 | 0 | $398.9K | $166.5K | 0.15% | -$232.4K |
| Aclaris Therapeutics, Inc.(ACRS) | 115,898 | 115,898 | 0 | $793.9K | $121.7K | 0.11% | -$672.2K |
| Burgerfi International IncW EXP 12 16 202 | 0 | 2,083,438 | +2,083,438 | $0 | $93.8K | 0.08% | +$93.8K |
| Microsoft Corporation(MSFT) | 100 | 100 | 0 | $31.6K | $37.6K | 0.03% | +$6.0K |
| Alphabet Inc.CL C(GOOG) | 100 | 100 | 0 | $13.2K | $14.1K | 0.01% | +$908 |
| CHEVRON CORP NEWCOM(CVX) | 46 | 0 | -46 | $7.8K | $0 | — | -$7.8K |
| DURECT CORPCOM NEW | 427,455 | 0 | -427,455 | $1.06M | $0 | — | -$1.06M |